A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for hereditary haemorrhagic telangiectasia (HHT), the second most common inherited ...
The new container ship, OOCL Piraeus, docks at the Port of Piraeus in Greece in 2023. Xinhua via Getty Images This interactive map tracks China’s growing maritime influence through investments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback